Potential Mechanisms for Thrombocytopenia Development With Trastuzumab Emtansine (T-Dm1)
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-2093
Full Text
Open PDFAbstract
Available in full text
Date
November 4, 2014
Authors
Publisher
American Association for Cancer Research (AACR)